Adiponectin: An update
Tóm tắt
Từ khóa
Tài liệu tham khảo
Scherer, 1995, A novel serum protein similar to C1q, produced exclusively in adipocytes, J Biol Chem, 270, 26746, 10.1074/jbc.270.45.26746
Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697
Maeda, 1996, cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1), Biochem Biophys Res Commun, 221, 286, 10.1006/bbrc.1996.0587
Nakano, 1996, Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma, J Biochem (Tokyo), 120, 803, 10.1093/oxfordjournals.jbchem.a021483
Arita, 1999, Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem Biophys Res Commun, 257, 79, 10.1006/bbrc.1999.0255
Hotta, 2000, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol, 20, 1595, 10.1161/01.ATV.20.6.1595
Ouchi, 1999, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473
Ouchi, 2000, Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway, Circulation, 102, 1296, 10.1161/01.CIR.102.11.1296
Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057
Kubota, 2002, Disruption of adiponectin causes insulin resistance and neointimal formation, J Biol Chem, 277, 25863, 10.1074/jbc.C200251200
Matsuda, 2002, Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis, J Biol Chem, 277, 37487, 10.1074/jbc.M206083200
Okamoto, 2002, Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice, Circulation, 106, 2767, 10.1161/01.CIR.0000042707.50032.19
Yamauchi, 2003, Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis, J Biol Chem, 278, 2461, 10.1074/jbc.M209033200
Shibata, 2005, Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms, Nat Med, 11, 1096, 10.1038/nm1295
Kato, 2006, Adiponectin acts as an endogenous antithrombotic factor, Arterioscler Thromb Vasc Biol, 26, 224, 10.1161/01.ATV.0000194076.84568.81
Kumada, 2003, Association of hypoadiponectinemia with coronary artery disease in men, Arterioscler Thromb Vasc Biol, 23, 85, 10.1161/01.ATV.0000048856.22331.50
Bouhali T, Brisson D, St Pierre J, Tremblay G, Perron P, Laprise C. et al. Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia. Atherosclerosis, in press.
Hotta, 2001, Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys, Diabetes, 50, 1126, 10.2337/diabetes.50.5.1126
Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724
Ma, 2002, Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin, J Biol Chem, 277, 34658, 10.1074/jbc.C200362200
Nawrocki, 2006, Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists, J Biol Chem, 281, 2654, 10.1074/jbc.M505311200
Lindsay, 2002, Adiponectin and development of type 2 diabetes in the Pima Indian population, Lancet, 360, 57, 10.1016/S0140-6736(02)09335-2
Spranger, 2003, Adiponectin and protection against type 2 diabetes mellitus, Lancet, 361, 226, 10.1016/S0140-6736(03)12255-6
Kadowaki, 2006, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest, 116, 1784, 10.1172/JCI29126
Wang, 2006, Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin, Proteomics, 6, 3862, 10.1002/pmic.200500840
Fruebis, 2001, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice, Proc Natl Acad Sci U S A, 98, 2005, 10.1073/pnas.041591798
Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat Med, 7, 941, 10.1038/90984
Wong, 2004, A family of Acrp30/adiponectin structural and functional paralogs, Proc Natl Acad Sci U S A, 101, 10302, 10.1073/pnas.0403760101
Hara, 2006, Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome, Diabetes Care, 29, 1357, 10.2337/dc05-1801
Ebinuma, 2006, A novel ELISA system for selective measurement of human adiponectin multimers by using proteases, Clin Chim Acta, 372, 47, 10.1016/j.cca.2006.03.014
Berg, 2001, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action, Nat Med, 7, 947, 10.1038/90992
Combs, 2001, Endogenous glucose production is inhibited by the adipose-derived protein Acrp30, J Clin Invest, 108, 1875, 10.1172/JCI14120
Bajaj, 2004, Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients, J Clin Endocrinol Metab, 89, 200, 10.1210/jc.2003-031315
Miyazaki, 2004, Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients, J Clin Endocrinol Metab, 89, 4312, 10.1210/jc.2004-0190
Bugianesi, 2005, Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity, J Clin Endocrinol Metab, 90, 3498, 10.1210/jc.2004-2240
Kahn, 2005, AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism, Cell Metab, 1, 15, 10.1016/j.cmet.2004.12.003
Kola, 2006, Expanding role of AMPK in endocrinology, Trends Endocrinol Metab, 17, 205, 10.1016/j.tem.2006.05.006
Viollet, 2006, Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders, J Physiol, 574, 41, 10.1113/jphysiol.2006.108506
Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat Med, 8, 1288, 10.1038/nm788
Tomas, 2002, Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation, Proc Natl Acad Sci U S A, 99, 16309, 10.1073/pnas.222657499
Civitarese, 2006, Role of adiponectin in human skeletal muscle bioenergetics, Cell Metab, 4, 75, 10.1016/j.cmet.2006.05.002
Andreelli, 2006, Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin, Endocrinology, 147, 2432, 10.1210/en.2005-0898
Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells, J Biol Chem, 279, 1304, 10.1074/jbc.M310389200
Shibata, 2004, Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling, J Biol Chem, 279, 28670, 10.1074/jbc.M402558200
Kobayashi, 2004, Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin, Circ Res, 94, e27, 10.1161/01.RES.0000119921.86460.37
Chen, 2003, Adiponectin stimulates production of nitric oxide in vascular endothelial cells, J Biol Chem, 278, 45021, 10.1074/jbc.M307878200
Waki, 2003, Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin, J Biol Chem, 278, 40352, 10.1074/jbc.M300365200
Yamauchi, 2003, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects, Nature, 423, 762, 10.1038/nature01705
Yamauchi, 2007, Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions, Nat Med, 13, 332, 10.1038/nm1557
Mao, 2006, APPL1 binds to adiponectin receptors and mediates adiponectin signaling and function, Nat Cell Biol, 8, 516, 10.1038/ncb1404
Hug, 2004, T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin, Proc Natl Acad Sci U S A, 101, 10308, 10.1073/pnas.0403382101
Tsuchida, 2004, Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity, J Biol Chem, 279, 30817, 10.1074/jbc.M402367200
Beylot, 2006, Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats, Metabolism, 55, 396, 10.1016/j.metabol.2005.09.016
Staiger, 2004, Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism, Diabetes, 53, 2195, 10.2337/diabetes.53.9.2195
Furukawa, 2004, Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, 114, 1752, 10.1172/JCI21625
Clement, 2004, Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects, FASEB J, 18, 1657, 10.1096/fj.04-2204com
Cancello, 2005, Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss, Diabetes, 54, 2277, 10.2337/diabetes.54.8.2277
Bruun, 2003, Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans, Am J Physiol Endocrinol Metab, 285, 527, 10.1152/ajpendo.00110.2003
Fasshauer, 2003, Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes, Biochem Biophys Res Commun, 301, 1045, 10.1016/S0006-291X(03)00090-1
Pietilainen, 2006, Acquired obesity increases CD68 and tumor necrosis factor-{alpha} and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins, J Clin Endocrinol Metab, 91, 2776, 10.1210/jc.2005-2848
Kobashi, 2005, Adiponectin inhibits endothelial synthesis of interleukin-8, Circ Res, 97, 1245, 10.1161/01.RES.0000194328.57164.36
Yokota, 2000, Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages, Blood, 96, 1723, 10.1182/blood.V96.5.1723
Chinetti, 2004, Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR, Biochem Biophys Res Commun, 314, 151, 10.1016/j.bbrc.2003.12.058
Sattar, 2006, Adiponectin and coronary heart disease: a prospective study and meta-analysis, Circulation, 114, 623, 10.1161/CIRCULATIONAHA.106.618918
Schaffler, 2005, Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease, Nat Clin Pract Gastroenterol Hepatol, 2, 273, 10.1038/ncpgasthep0186
Cancello, 2006, Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity, Diabetes, 55, 1554, 10.2337/db06-0133
Kelesidis, 2006, Adiponectin and cancer: a systematic review, Br J Cancer, 94, 1221, 10.1038/sj.bjc.6603051
Lara-Castro, 2006, Adiponectin multimeric complexes and the metabolic syndrome trait cluster, Diabetes, 55, 249, 10.2337/diabetes.55.01.06.db05-1105
Bobbert, 2005, Changes of adiponectin oligomer composition by moderate weight reduction, Diabetes, 54, 2712, 10.2337/diabetes.54.9.2712
Rossi, 2005, Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats, Am J Physiol Regul Integr Comp Physiol, 289, R486, 10.1152/ajpregu.00846.2004
Flachs, 2006, Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet, Diabetologia, 49, 394, 10.1007/s00125-005-0053-y
Neschen, 2006, Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice, Diabetes, 55, 924, 10.2337/diabetes.55.04.06.db05-0985
Todoric, 2006, Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids, Diabetologia, 49, 2109, 10.1007/s00125-006-0300-x
Maeda, 2001, PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein, Diabetes, 50, 2094, 10.2337/diabetes.50.9.2094
Combs, 2002, Induction of adipocyte complement-related protein of 30kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization, Endocrinology, 143, 998, 10.1210/en.143.3.998
Yu, 2002, The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects, Diabetes, 51, 2968, 10.2337/diabetes.51.10.2968
Phillips, 2003, Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy, Diabetes, 52, 667, 10.2337/diabetes.52.3.667
Iwaki, 2003, Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors, Diabetes, 52, 1655, 10.2337/diabetes.52.7.1655
Tsuchida, 2005, Peroxisome proliferators activated receptor (PPAR){alpha} activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPAR{alpha}, PPAR{gamma}, and their combination, Diabetes, 54, 3358, 10.2337/diabetes.54.12.3358
Pajvani, 2004, Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity, J Biol Chem, 279, 12152, 10.1074/jbc.M311113200
van Gaal, 2005, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, 365, 1389, 10.1016/S0140-6736(05)66374-X
Despres, 2005, Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia, N Engl J Med, 353, 2121, 10.1056/NEJMoa044537
Scheen, 2006, Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study, Lancet, 368, 1660, 10.1016/S0140-6736(06)69571-8
Pi-Sunyer, 2006, Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial, JAMA, 295, 761, 10.1001/jama.295.7.761
Bensaid, 2003, The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells, Mol Pharmacol, 63, 908, 10.1124/mol.63.4.908